Rheumatoid arthritis is a systemic autoimmune rheumatic disorder of unknown etiology.
It is the most common form of inflammatory arthritis.
Patient usually complains of joint pain and/or swelling with morning stiffness that lasts for more than an hour.
Goals of treatment are clinical & radiological remission of disease and to reduce functional limitations & permanent joint damage.
Prolonged repetitive physical work such as those tasks associated with construction, for example, increases the risk of developing rheumatoid arthritis (RA), according to the results of a population-based case-control Swedish study presented during the European League Against Rheumatism (EULAR) annual congress held recently in London, England.
A biodegradable nanoparticle delivery system loaded with methotrexate and targeted to inflamed synovial tissue halted the inflammatory process in rat models of rheumatoid arthritis compared to standard free methotrexate therapy.
In patients with type 2 diabetes mellitus (T2DM), advanced glycation end products play a role in bone fragility, according to a new study presented at the recently concluded 5th Scientific Meeting of the Asian Federation of Osteoporosis Societies (AFOS 2017).